[Federal Register Volume 89, Number 83 (Monday, April 29, 2024)]
[Notices]
[Page 33343]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09080]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness
(USD(P&R)), Department of Defense (DoD).
ACTION: Notice of Federal advisory committee meeting.
-----------------------------------------------------------------------
SUMMARY: The DoD is publishing this notice to announce that the
following Federal Advisory Committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (UFBAP) will take place.
DATES: Open to the public Wednesday, June 26, 2024, from 10:00 a.m. to
1:00 p.m. Eastern Standard Time.
ADDRESSES: The meeting will be held telephonically or via conference
call. The phone number for the remote access on June 26, 2024, is:
CONUS: 1-888-831-4306; OCONUS: 1-210-234-8694; PARTICIPANT CODE:
9136304.
These numbers and the dial-in instructions will also be posted on
the UFBAP website at: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP.
FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO)
Captain Tiffany F. Cline, USN, 703-681-2890 (voice), [email protected] (email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP. The most up-to-date changes to the meeting
agenda can be found on the website.
SUPPLEMENTARY INFORMATION: This meeting is being held under the
provisions of chapter 10 of title 5, United States Code (U.S.C.)
(commonly known as ``the Federal Advisory Committee Act'' or ``FACA''),
5 U.S.C. 552b (commonly known as the ``Government in the Sunshine
Act''), and 41 CFR 102-3.140 and 102-3.150.
Purpose of the Meeting: The UFBAP will review and comment on
recommendations made by the Pharmacy and Therapeutics Committee to the
Director, Defense Health Agency regarding the Uniform Formulary.
Agenda:
1. 10:00 a.m.-10:10 a.m. Sign in for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
a. Welcome, Opening Remarks, and Introduction of UFBAP Members by
CAPT Tiffany F. Cline, DFO, UFBAP
b. Public Written Comments by CAPT Tiffany F. Cline, DFO, UFBAP
c. Opening Remarks by Dr. Pamela Schweitzer, UFBAP Chair
d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
a. Closing Remarks by UFBAP Co-Chair
b. Closing Remarks by DFO, UFBAP
Meeting Accessibility: Pursuant to 5 U.S.C. 1009(a)(1) and 41 CFR
102-3.140 through 102-3.165, and subject to the availability of phone
lines, this meeting is open to the public. Telephone lines are limited
and available to the first 220 people dialing in. There will be 220
lines total: 200 domestic and 20 international, including leader lines.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and 5 U.S.C. 1009(a)(3), interested persons or organizations
may submit written statements to the UFBAP about its mission and/or the
agenda to be addressed in this public meeting. Written statements
should be submitted to the UFBAP's DFO. The DFO's contact information
can be found in the FOR FURTHER INFORMATION CONTACT section of this
notice. Written comments or statements must be received by the UFBAP's
DFO at least five (5) calendar days prior to the meeting so they may be
made available to the UFBAP for its consideration prior to the meeting.
Written comments received are releasable to the public. The DFO will
review all submitted written statements and provide copies to UFBAP.
Dated: April 23, 2024.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2024-09080 Filed 4-26-24; 8:45 am]
BILLING CODE 6001-FR-P